Medical release archive

Lynparza (olaparib) maintenance treatment offers sustained quality of life alongside improved progression-free survival in women with BRCA-mutated ovarian cancer

US FDA approves Symbicort (budesonide/formoterol) for the treatment of asthma in paediatric patients

AstraZeneca supports the publication of the 2017 GOLD strategy for improving COPD diagnosis, management and prevention

Early data demonstrate clinical activity of acalabrutinib in difficult-to-treat chronic lymphocytic leukaemia

Arthritis and Rheumatology publishes positive Phase II data on anifrolumab in lupus

EUCLID trial results for BRILINTA/BRILIQUE presented at the American Heart Association Scientific Sessions

Durvalumab shows promising preliminary early data in lung and head & neck cancers

Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 diabetes

AstraZeneca announces two new Phase IIIb trials for Forxiga in chronic kidney disease and chronic heart failure

AstraZeneca presents further evidence for the potential of AZD9291 in first-line and pre-treated non-small cell lung cancer